Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1998 | 12-1997 | 09-1997 | 06-1997 | 03-1997 | |
| Sales | 3,278 | 2,935 | 3,629 | 3,266 | 2,001 |
| Gross Profit | 3,270 | 2,935 | 3,629 | 3,266 | 2,001 |
| Operating Expenses | 10,330 | 0 | 8,449 | 8,854 | 7,904 |
| Operating Income | -7,052 | 2,935 | -4,820 | -5,588 | -5,903 |
| Interest Expense | 100 | 0 | 91 | 97 | 109 |
| Other Income | 952 | 0 | 654 | 808 | 374 |
| Pre-tax Income | -6,200 | 2,935 | -4,257 | -4,877 | -5,638 |
| Net Income Continuous | -6,200 | -8,253 | -4,258 | -4,877 | -5,639 |
| Net Income | $-6,200 | $-8,253 | $-4,258 | $-4,877 | $-5,639 |
| EPS Basic Total Ops | -4,799.04 | -6,718.66 | -3,959.21 | -4,439.11 | -6,838.63 |
| EPS Basic Continuous Ops | -4,769.23 | -6,877.50 | -3,870.91 | -4,433.64 | -7,048.75 |
| EPS Diluted Total Ops | -4,799.04 | -6,718.66 | -3,959.20 | -4,439.10 | -6,838.65 |
| EPS Diluted Continuous Ops | -4,769.23 | -6,877.50 | -3,870.91 | -4,433.64 | -7,048.75 |
| EBITDA(a) | $-6,622 | $2,935 | $-4,370 | $-5,152 | $-5,498 |